SOLV vs XLK
Solventum Corp. (SOLV) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
XLK does not have a complete income-statement cache yet.
SOLV currently screens at market cap $12.91B and trailing P/E 9.1. XLK currently screens at market cap $0.
Not investment advice. Open the SOLV and XLK stock pages for the full models.
Not investment advice.